Skip to main content
GREEN CROSS WellBeing Corporation logo

GREEN CROSS WellBeing Corporation — Investor Relations & Filings

Ticker · 234690 ISIN · KR7234690006 KO Manufacturing
Open in API
Filings indexed 182 across all filing types
Latest filing 2026-05-15 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 234690

About GREEN CROSS WellBeing Corporation

https://www.greencrosswb.com/en/

GREEN CROSS WellBeing Corporation is a company focused on promoting human health through personalized nutrition solutions. Its primary business areas include the development and manufacturing of prescription nutritional injections, such as its placental injection Laennec. The company also provides a range of health functional foods and supplements, including the Dr. PNT brand, which offers customized nutrient solutions based on individual health needs and expert consultation. Further product lines include cosmetics derived from proprietary cell culture technology. Research and development is a key focus, with active programs in customized probiotics tailored to different life stages, the discovery of new functional materials from natural products, and the development of novel pharmaceutical treatments for conditions such as Cancer Cachexia.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 95% confidence The document is titled “분기보고서” (Quarterly Report) covering the period 2026.01.01–2026.03.31 and contains detailed company overview, business performance, financial data, and analysis for the first quarter. It is a full interim/quarterly financial report filed with the Financial Supervisory Service and Korean Exchange, meeting the definition of an Interim/Quarterly Report (IR). Q1 2026
2026-05-15 Korean
파생상품거래손실발생
Regulatory Filings Classification · 85% confidence The document is a brief regulatory announcement detailing the occurrence of a derivative transaction loss (파생상품거래손실발생), with figures, reasons, and date. It is not a full financial report (no full financial statements), nor an earnings release or annual/interim report. It is an ad-hoc compliance disclosure under exchange rules. Therefore, it falls under the fallback category “Regulatory Filings (RNS).”
2026-05-15 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Classification · 95% confidence The document is titled as a preliminary (잠정) consolidated financial performance report for the first quarter of 2026, with detailed financial figures for sales, operating profit, and net income compared to previous periods. It explicitly states that the figures are provisional and prepared under Korean IFRS, and it is intended for investors and analysts. The document length is 2413 characters, which is relatively short and resembles a brief earnings announcement rather than a full interim report with comprehensive financial statements and analysis. There is no indication that this is a full quarterly report (IR) or annual report (10-K). The document is a preliminary earnings disclosure, which aligns with the definition of an Earnings Release (ER).
2026-05-07 Korean
기타시장안내(약명및영문명)
Regulatory Filings Classification · 80% confidence The document is a short market notice in Korean announcing the change of the company’s English name (‘영문상호’) effective on a specified listing date. It does not present financial results, meeting materials, dividends, or a full report, but rather a regulatory announcement. It therefore falls under the general Regulatory Filings category (RNS).
2026-04-24 Korean
[기재정정]전환청구권행사
Share Issue/Capital Change Classification · 85% confidence The document is a corporate disclosure (in Korean) reporting the exercise of conversion rights on convertible bonds, including number of shares issued and changes to listing dates. This is an announcement of a change in capital structure through the issuance of new shares upon conversion. This aligns with the “Share Issue/Capital Change” category (SHA).
2026-04-17 Korean
[기재정정]전환청구권행사
Share Issue/Capital Change Classification · 90% confidence The document is a Korean corporate disclosure detailing the exercise of convertible bond conversion rights (“전환청구권 행사”), including corrected listing date (‘정정신고’) and tables of shares issued upon conversion and remaining bond balances. This is an announcement of new share issuance due to conversion of bonds, which falls under Share Issue/Capital Change (SHA).
2026-04-15 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.